Skip to main content
Terug
Watch Compare

ASSEMBLY BIOSCIENCES, INC.

Datakwaliteit: 100%
ASMB
Nasdaq Manufacturing Chemicals
€ 29,87
▲ € 0,52 (1,77%)
Marktkapitalisatie: 473,82 M
Prijs
€ 29,87
Marktkapitalisatie
473,82 M
Dagbereik
€ 29,10 — € 30,18
52-Weeksbereik
€ 7,90 — € 39,71
Volume
76.400
Openen € 29,10
50D / 200D Gem.
€ 28,04
6,55% above
50D / 200D Gem.
€ 27,16
9,98% above

Quick Summary

Belangrijkste Punten

Negative free cash flow of -41,16 M
Capital efficient — spends only 0,09% of revenue on capex

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-6,10%
Boven sectorgemiddelde (-53,41%)
ROIC-8,70%
Net Margin-8,47%
Op. Margin-16,76%

Veiligheid

Debt / Equity
N/A
Current Ratio4,44
Interest CoverageN/A

Waardering

PE (TTM)
-77,40
Onder sectorgemiddelde (-1,48)
P/B Ratio2,59
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -77,4 -1,5
P/B 2,6 1,6
ROE % -6,1 -53,4
Net Margin % -8,5 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

ETFs Holding This Stock

BRSIX BRSIX
0,13% weight
AVUV logo AVUV Avantis U.S. Small Cap Value ETF
0,00% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 72,30 M Net Income (TTM) -6,12 M
ROE -6,10% ROA -3,82%
Gross Margin N/A Operating Margin -16,76%
Net Margin -8,47% Free Cash Flow (TTM) -41,16 M
ROIC -8,70% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4,44
Interest Coverage N/A Asset Turnover 0,45
Working Capital 183,43 M Tangible Book Value 182,70 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -77,40 Forward P/E N/A
P/B Ratio 2,59 P/S Ratio 6,55
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -8,69%
Market Cap 473,82 M Enterprise Value 451,29 M
Per Share
EPS (Diluted TTM) -0,55 Revenue / Share 4,56
FCF / Share -2,59 OCF / Share -2,59
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,09% FCF Conversion 672,31%
SBC-Adj. FCF -45,17 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 72,30 M — — — —
Net Income -6,12 M -40,18 M -61,23 M -93,09 M -129,86 M
EPS (Diluted) -0,55 -6,69 -13,38 -1,92 —
Gross Profit — — — — —
Operating Income -12,12 M -45,42 M -64,65 M -94,11 M -132,69 M
EBITDA — — — — —
R&D Expenses 64,81 M 55,93 M 48,90 M 69,98 M 68,52 M
SG&A Expenses — — — — —
D&A 129.000,0 129.000,0 450.000,0 498.000,0 466.000,0
Interest Expense — — — — —
Income Tax 0,0 330.000,0 33.000,0 0,0 -2,53 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 257,59 M 119,17 M 136,82 M 101,79 M 191,06 M
Total Liabilities 50,84 M 85,81 M 95,73 M 19,13 M 22,13 M
Shareholders' Equity 206,75 M 33,36 M 41,10 M 82,66 M 168,93 M
Total Debt — — — — —
Cash & Equivalents 58,45 M 38,34 M 19,84 M 52,42 M 45,63 M
Current Assets 254,55 M 115,50 M 133,79 M 96,97 M 154,20 M
Current Liabilities 48,78 M 47,80 M 39,23 M 16,30 M 16,07 M